Related references
Note: Only part of the references are listed.Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials
T. Bieber et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
Mette Deleuran et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy
Hirokazu Arakawa et al.
ALLERGOLOGY INTERNATIONAL (2020)
Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)
L. M. Howells et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials
E. L. Simpson et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
David M. Pariser et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
Hidemi Nakagawa et al.
JOURNAL OF DERMATOLOGY (2020)
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
Hidemi Nakagawa et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis A Randomized Clinical Trial
Kristian Reich et al.
JAMA DERMATOLOGY (2020)
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
Emma Guttman-Yassky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape
Mark Boguniewicz et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study
H. Nakagawa et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
The Microevolution and Epidemiology of Staphylococcus aureus Colonization during Atopic Eczema Disease Flare
Catriona P. Harkins et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Landon K. Oetjen et al.
CELL (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Atopic dermatitis and filaggrin
Beatriz Cabanillas et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Lifestyle Guidance for Pediatric Patients with Atopic Dermatitis Based on Age-Specific Physiological Function of Skin
Hiroyuki Murota et al.
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY (2016)
Safety of Topical Corticosteroids in Pregnancy
Ching-Chi Chi et al.
JAMA DERMATOLOGY (2016)
Dysbiosis and Staphyloccus aureus Colonization Drives Inflammation in Atopic Dermatitis
Tetsuro Kobayashi et al.
IMMUNITY (2015)
Photo(chemo) therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research
F. M. Garritsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Guidelines of care for the management of atopic dermatitis
Robert Sidbury et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods
C. R. Charman et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Fungal protein MGL_1304 in sweat is an allergen for atopic dermatitis patients
Takaaki Hiragun et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Effects of a Short-Term Parental Education Program on Childhood Atopic Dermatitis: A Randomized Controlled Trial
Masaki Futamura et al.
PEDIATRIC DERMATOLOGY (2013)
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Heidi H. Kong et al.
GENOME RESEARCH (2012)
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
John J. O'Shea et al.
IMMUNITY (2012)
Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis
Hiroyuki Murota et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials
J. Schmitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Tight junction defects in patients with atopic dermatitis
Anna De Benedetto et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Online video improves clinical outcomes in adults with atopic dermatitis: A randomized controlled trial
April W. Armstrong et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
The Role of Contact Allergy in Atopic Dermatitis
Luz S. Fonacier et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD)
K. Kondo-Endo et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Effects of skin surface temperature on epidermal permeability barrier homeostasis
Mitsuhiro Denda et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study
M. Caproni et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial
D Staab et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
IL-31: A new link between T cells and pruritus in atopic skin inflammation
E Sonkoly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Reduced dermal infiltration of cytokineexpressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment
D Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Impaired sweating function in adult atopic dermatitis: results of the quantitative sudomotor axon reflex test
K Eishi et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy
H Mygind et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2002)
Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months
SF Friedlander et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
JM Hanifin et al.
EXPERIMENTAL DERMATOLOGY (2001)
Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis
JA Ellison et al.
PEDIATRICS (2000)
Share Paper
